Cytarabine Injection, Solution
Product Images NDC 68083-337

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cytarabine (NDC 68083-337). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cytarabine-spl-carton-label (Cytarabine Spl Carton Label)

Label for Cytarabine Injection 2 grams per 20 mL (100 mg per mL) solution for injection. For intravenous, intrathecal, and subcutaneous use. The label includes storage instructions, cautions about cytotoxicity, and manufacturer details: Gland Pharma Limited, Visakhapatnam, India. The vial size is 20 mL single-dose, preservative-free, and sterile.*

FDA Label Image

Cytarabine-spl-structure (Cytarabine Spl Structure)

Chemical structure of Cytarabine (C9H13N3O5), illustrating the molecular formula and arrangement of atoms. The molecular weight is 243.22 g/mol.*

FDA Label Image

Cytarabine-spl-vial-label (Cytarabine Spl Vial Label)

Label for Cytarabine Injection 2 grams per 20 mL (100 mg per mL) single-dose vial by Gland Pharma Limited. Intended for intravenous, intrathecal, and subcutaneous use. The label notes storage at 20° to 25°C, preservative-free, sterile solution, and includes dosing and manufacturing information along with barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.